Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von GraveDigger 

Idexx Laboratories Inc. diskutieren

Idexx Laboratories Inc.

WKN: 888210 / Symbol: IDXX / Name: IDEXX Labs / Aktie / Ausrüstung & Versorgung / Large Cap /

524,00 €
-0,42 %

Sell Idexx Laboratories Inc.

Buy Idexx Laboratories Inc.

T-Shirt printing design online : United Graphic offers the best custom t shirts Online.We can design custom logo t shirts for you. Free Shipping, Place the order online.

Sell Idexx Laboratories Inc.

Sell Idexx Laboratories Inc.

Einschätzung Buy
Rendite (%) 16,73 %
Kursziel 541,80
Veränderung
Endet am 23.03.24

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Morgan Stanley from $543.00 to $590.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat

IDEXX Laboratories, Inc. (NASDAQ: IDXX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for IDXX provided by MarketBeat

Einschätzung Buy
Rendite (%) 12,37 %
Kursziel 547,68
Veränderung
Endet am 03.08.24

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Morgan Stanley from $590.00 to $600.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat

Einschätzung Buy
Rendite (%) 29,49 %
Kursziel 466,10
Veränderung
Endet am 03.11.24

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $578.00 to $500.00. They now have a "buy" rating on the stock.
Ratings data for IDXX provided by MarketBeat

Einschätzung Buy
Rendite (%) 33,25 %
Kursziel 488,51
Veränderung
Endet am 06.11.24

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Piper Sandler from $520.00 to $525.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,61 %
Kursziel 557,75
Veränderung
Endet am 07.12.24

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $602.00 price target on the stock.
Ratings data for IDXX provided by MarketBeat

IDEXX Laboratories, Inc. (NASDAQ: IDXX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for IDXX provided by MarketBeat

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for IDXX provided by MarketBeat

Einschätzung Buy
Rendite (%) 10,49 %
Kursziel 598,91
Veränderung
Endet am 17.01.25

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $500.00 to $650.00. They now have a "buy" rating on the stock.
Ratings data for IDXX provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,49 %
Kursziel 609,54
Veränderung
Endet am 06.02.25

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at Barclays PLC from $605.00 to $655.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,68 %
Kursziel 586,03
Veränderung
Endet am 06.02.25

IDEXX Laboratories, Inc. (NASDAQ: IDXX) had its price target raised by analysts at JPMorgan Chase & Co. from $600.00 to $630.00. They now have an "overweight" rating on the stock.
Ratings data for IDXX provided by MarketBeat